Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Statistics in Medicine
|
September 3, 2004
Improved confidence intervals for a binomial parameter following a group sequential phase II clinical trial
Myron N Chang
Statistics in Medicine
|
August 25, 2005
One- and two-stage designs for stratified phase II clinical trials
Wendy B London, Myron N Chang
Controlled Clinical Trials
|
May 26, 2004
Samples of exact k-stage group sequential designs for Phase II and Pilot studies
James L Kepner, Myron N Chang
Statistics in Medicine
|
January 11, 2007
One- and two-stage designs for phase II window studies
Myron N Chang, Meenakshi Devidas, James Anderson
Statistics in Medicine
|
March 17, 2012
Improved two-stage tests for stratified phase II cancer clinical trials
Myron N Chang, Jonathan J Shuster, Wei Hou
Journal of Biopharmaceutical Statistics
|
January 19, 2012
Phase II cancer clinical trials with heterogeneous patient populations
Sin-Ho Jung, Myron N Chang, Sun J Kang
Journal of Biopharmaceutical Statistics
|
March 19, 2004
Sample sizes based on exact unconditional tests for phase II clinical trials with historical controls
Myron N Chang, Jonathan J Shuster, James L Kepner
Statistics in Medicine
|
May 1, 2013
Designs for randomized phase II clinical trials with two treatment arms
Wei Hou, Myron N Chang, Sin-Ho Jung, et al.
Statistical Applications in Genetics and Molecular Biology
|
February 19, 2009
Score statistics for mapping quantitative trait loci
Myron N Chang, Rongling Wu, Samuel S Wu, et al.
Journal of Health Care for the Poor and Underserved
|
February 12, 2008
The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer
Satoshi Anai, Kogenta Nakamura, Myron N Chang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Statistics in Medicine
|
September 3, 2004
Improved confidence intervals for a binomial parameter following a group sequential phase II clinical trial
Myron N Chang
Statistics in Medicine
|
August 25, 2005
One- and two-stage designs for stratified phase II clinical trials
Wendy B London, Myron N Chang
Controlled Clinical Trials
|
May 26, 2004
Samples of exact k-stage group sequential designs for Phase II and Pilot studies
James L Kepner, Myron N Chang
Statistics in Medicine
|
January 11, 2007
One- and two-stage designs for phase II window studies
Myron N Chang, Meenakshi Devidas, James Anderson
Statistics in Medicine
|
March 17, 2012
Improved two-stage tests for stratified phase II cancer clinical trials
Myron N Chang, Jonathan J Shuster, Wei Hou
Journal of Biopharmaceutical Statistics
|
January 19, 2012
Phase II cancer clinical trials with heterogeneous patient populations
Sin-Ho Jung, Myron N Chang, Sun J Kang
Journal of Biopharmaceutical Statistics
|
March 19, 2004
Sample sizes based on exact unconditional tests for phase II clinical trials with historical controls
Myron N Chang, Jonathan J Shuster, James L Kepner
Statistics in Medicine
|
May 1, 2013
Designs for randomized phase II clinical trials with two treatment arms
Wei Hou, Myron N Chang, Sin-Ho Jung, et al.
Statistical Applications in Genetics and Molecular Biology
|
February 19, 2009
Score statistics for mapping quantitative trait loci
Myron N Chang, Rongling Wu, Samuel S Wu, et al.
Journal of Health Care for the Poor and Underserved
|
February 12, 2008
The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer
Satoshi Anai, Kogenta Nakamura, Myron N Chang, et al.
Page
of 3